Cydectin 1% w/v Solution for Injection for Sheep

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Buy It Now

Active ingredient:

Moxidectin

Available from:

Zoetis UK Limited

ATC code:

QP54AB02

INN (International Name):

Moxidectin

Pharmaceutical form:

Solution for injection

Prescription type:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Therapeutic group:

Sheep

Therapeutic area:

Endectocide

Authorization status:

Authorized

Authorization date:

1998-07-17

Summary of Product characteristics

                                Revised: August 2020
AN: 00663/2020
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cydectin 1% w/v Solution for Injection for Sheep
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH ML CONTAINS:
ACTIVE SUBSTANCE:
Moxidectin
10.0 mg
EXCIPIENT(S):
Benzyl Alcohol
40.0 mg
Butylhydroxytoluene (E321)
2.5 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
A sterile, clear to pale yellow aqueous solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CYDECTIN is indicated for:
Prevention and treatment of Psoroptic mange (_Psoroptes ovis_):
Clinical cure:
2 injections 10 days apart.
Preventive efficacy: 1 injection.
Treatment and control of infestations caused by moxidectin sensitive
strains of:
Gastro-intestinal nematodes:
•
_Haemonchus contortus_
•
_Teladorsagia circumcincta _(including inhibited larvae)
•
_Trichostrongylus axei _(adults)
•
_Trichostrongylus colubriformis_ (adults and L3)
•
_Nematodirus spathiger_ (adults)
Revised: August 2020
AN: 00663/2020
Page 2 of 7
•
_Cooperia curticei _(adults)
•
_Cooperia punctata _(adults)
•
_Gaigeria pachyscelis_ (L3)
•
_Oesophagostomum columbianum _(L3)
•
_Chabertia ovina _(adults)
Respiratory tract nematode:
•
_Dictyocaulus filaria _(adults)
Larvae of Diptera
•
Oestrus ovis : L1, L2, L3
CYDECTIN has a persistent effect in preventing infestation or
reinfestation for:
- At least 4 weeks against _Psoroptes ovis_
- 5 weeks against _Teladorsagia circumcincta_ and _Haemonchus
contortus_
- 4 weeks against _Gaigeria pachyscelis _and _Oesophagostomum
columbianum_
- 2 weeks against _Trichostrongylus colubriformis_
Trials
have
shown
that
the
product
may
be
effective
against
strains
of
_Haemonchus _
_contortus _
resistant
to
benzimidazoles,
ivermectin
and
doramectin.
4.3
CONTRAINDICATIONS
Do not use in animals vaccinated against footrot.
4.4
SPECIAL WARNINGS
Care should be taken to avoid the following practices becau
                                
                                Read the complete document
                                
                            

Search alerts related to this product